The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints
Jennifer Neumann(Heidelberg University), Min Li‐Weber(German Cancer Research Center)
Cited by 33
Related Papers
Targeting CDK9 by wogonin and related natural flavones potentiates the anti‐cancer efficacy of the Bcl‐2 family inhibitor ABT‐263
|International Journal of Cancer|2014|61